Literature DB >> 26124457

Association of anemia and renal dysfunction with in-hospital mortality among patients hospitalized for acute heart failure syndromes with preserved or reduced ejection fraction.

Katsuya Kajimoto1, Naoki Sato2, Teruo Takano3.   

Abstract

BACKGROUND: The aim of this study was to evaluate the association of anemia and renal dysfunction with in-hospital outcomes in acute heart failure syndromes patients with preserved or reduced ejection fraction. METHODS AND
RESULTS: Of the 4842 patients enrolled in the Acute Decompensated Heart Failure Syndromes (ATTEND) registry, 4693 patients were evaluated to investigate the association among anemia, renal dysfunction, a preserved or reduced ejection fraction and in-hospital mortality. They were divided into four groups based on hemoglobin and estimated glomerular filtration rate at admission. The in-hospital mortality rate was 5.9% and 6.9% of the preserved and reduced ejection fraction groups, respectively. After adjustment for multiple comorbidities, there was no association of either anemia or renal dysfunction alone with in-hospital mortality in preserved ejection fraction patients, but the combination of anemia and renal dysfunction was associated with a somewhat higher risk of in-hospital mortality than that without either condition (odds ratio (OR), 2.75; 95% confidence interval (CI), 0.72-10.41; p=0.137). In reduced ejection fraction patients, adjusted analysis showed that a significantly higher risk of in-hospital mortality was associated with anemia alone (OR, 2.56; 95% CI, 1.10 -5.94; p=0.029) and with anemia plus renal dysfunction (OR, 2.34; 95% CI, 1.09-5.03; p=0.029) relative to the risk without either condition.
CONCLUSIONS: Our findings demonstrate that anemia combined with renal dysfunction is not a risk factor for in-hospital mortality in patients with a preserved ejection fraction, whereas anemia is an independent predictor of in-hospital mortality risk in reduced ejection fraction patients regardless of renal dysfunction.

Entities:  

Keywords:  Acute heart failure syndromes; anemia; in-hospital mortality; renal dysfunction

Mesh:

Year:  2016        PMID: 26124457     DOI: 10.1177/2048872615593387

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  5 in total

Review 1.  Heart failure with preserved ejection fraction: a nephrologist-directed primer.

Authors:  Baris Afsar; Patrick Rossignol; Loek van Heerebeek; Walter J Paulus; Kevin Damman; Stephane Heymans; Vanessa van Empel; Alan Sag; Alan Maisel; Mehmet Kanbay
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

2.  Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?

Authors:  Yumiko Kanzaki; Masako Yuki; Ken-Ichiro Yamamura; Yoshifumi Narumi; Nobukazu Ishizaka
Journal:  Heart Vessels       Date:  2016-02-20       Impact factor: 2.037

3.  Heart failure epidemiology and novel treatments in Japan: facts and numbers.

Authors:  Masaaki Konishi; Junichi Ishida; Jochen Springer; Stephan von Haehling; Yoshihiro J Akashi; Hiroaki Shimokawa; Stefan D Anker
Journal:  ESC Heart Fail       Date:  2016-08-02

4.  Incidence and impact of cardiorenal anaemia syndrome on all-cause mortality in acute heart failure patients stratified by left ventricular ejection fraction in the Middle East.

Authors:  Mohammed Al-Jarallah; Rajesh Rajan; Ibrahim Al-Zakwani; Raja Dashti; Bassam Bulbanat; Kadhim Sulaiman; Alawi A Alsheikh-Ali; Prashanth Panduranga; Khalid F AlHabib; Jassim Al Suwaidi; Wael Al-Mahmeed; Hussam AlFaleh; Abdelfatah Elasfar; Ahmed Al-Motarreb; Mustafa Ridha; Nooshin Bazargani; Nidal Asaad; Haitham Amin
Journal:  ESC Heart Fail       Date:  2018-10-12

5.  Renal function and anemia in relation to short- and long-term prognosis of patients with acute heart failure in the period 1985-2008: A clinical cohort study.

Authors:  Jan C van den Berge; Alina A Constantinescu; Ron T van Domburg; Milos Brankovic; Jaap W Deckers; K Martijn Akkerhuis
Journal:  PLoS One       Date:  2018-08-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.